Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Select Medical Holdings (SEM) Other Operating Expenses (2018 - 2025)

Select Medical Holdings (SEM) has disclosed Other Operating Expenses for 7 consecutive years, with $808.0 million as the latest value for Q4 2024.

  • On a quarterly basis, Other Operating Expenses rose 263085.02% to $808.0 million in Q4 2024 year-over-year; TTM through Sep 2025 was $808.0 million, a 20665.3% increase, with the full-year FY2024 number at $4.7 billion, up 309275.96% from a year prior.
  • Other Operating Expenses was $808.0 million for Q4 2024 at Select Medical Holdings, up from $1.3 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $808.0 million in Q4 2024 to a low of -$131.7 million in Q4 2021.
  • A 5-year average of $47.6 million and a median of $2.0 million in 2021 define the central range for Other Operating Expenses.
  • Peak YoY movement for Other Operating Expenses: crashed 2294.7% in 2021, then surged 263085.02% in 2024.
  • Select Medical Holdings' Other Operating Expenses stood at $6.0 million in 2020, then plummeted by 2294.7% to -$131.7 million in 2021, then surged by 103.95% to $5.2 million in 2022, then crashed by 94.1% to $307000.0 in 2023, then soared by 263085.02% to $808.0 million in 2024.
  • Per Business Quant, the three most recent readings for SEM's Other Operating Expenses are $808.0 million (Q4 2024), $1.3 million (Q3 2024), and -$2000.0 (Q2 2024).